Dengue Seroprevalence and Seroconversion in Urban and Rural Populations in Northeastern Thailand and Southern Laos
- PMID: 33297445
- PMCID: PMC7731008
- DOI: 10.3390/ijerph17239134
Dengue Seroprevalence and Seroconversion in Urban and Rural Populations in Northeastern Thailand and Southern Laos
Erratum in
-
Correction: Doum, D., et al. Dengue Seroprevalence and Seroconversion in Urban and Rural Populations in Northeastern Thailand and Southern Laos. Int. J. Environ. Res. Public Health 2020, 17, 9134.Int J Environ Res Public Health. 2021 Feb 4;18(4):1439. doi: 10.3390/ijerph18041439. Int J Environ Res Public Health. 2021. PMID: 33557444 Free PMC article.
Abstract
Dengue is the most rapidly spreading mosquito-borne viral disease in the world. The detection of clinical cases enables us to measure the incidence of dengue infection, whereas serological surveys give insights into the prevalence of infection. This study aimed to determine dengue seroprevalence and seroconversion rates in northeastern Thailand and southern Laos and to assess any association of mosquito control methods and socioeconomic factors with dengue virus (DENV) infection. Cross-sectional seroprevalence surveys were performed in May and November 2019 on the same individuals. Blood samples were collected from one adult and one child, when possible, in each of 720 randomly selected households from two urban and two rural sites in both northeastern Thailand and southern Laos. IgG antibodies against DENV were detected in serum using a commercial enzyme-linked immunosorbent assay (ELISA) kit. Overall, 1071 individuals participated in the study. The seroprevalence rate was high (91.5%) across all 8 study sites. Only age and province were associated with seroprevalence rates. There were 33 seroconversions during the period from May to November, of which seven reported fever. More than half of the seroconversions occurred in the rural areas and in Laos. Dengue seroconversion was significantly associated with young age (<15 years old), female gender, province, and duration of living in the current residence. No socioeconomic factors or mosquito control methods were found to be associated with seroprevalence or seroconversion. Notably, however, the province with most seroconversions had lower diurnal temperature ranges than elsewhere. In conclusion, our study has highlighted the homogeneity of dengue exposure across a wide range of settings and most notably those from rural and urban areas. Dengue can no longer be considered to be solely an urban disease nor necessarily one linked to poverty.
Keywords: DENV; dengue; seroconversion; seroprevalence; socioeconomic factors.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Dengue seroprevalence, seroconversion and risk factors in Dhaka, Bangladesh.PLoS Negl Trop Dis. 2017 Mar 23;11(3):e0005475. doi: 10.1371/journal.pntd.0005475. eCollection 2017 Mar. PLoS Negl Trop Dis. 2017. PMID: 28333935 Free PMC article.
-
Seroprevalence of dengue among healthy adults in a rural community in Southern Malaysia: a pilot study.Infect Dis Poverty. 2018 Jan 16;7(1):1. doi: 10.1186/s40249-017-0384-1. Infect Dis Poverty. 2018. PMID: 29335021 Free PMC article.
-
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia: implications for vaccine introduction.Int J Infect Dis. 2017 May;58:27-36. doi: 10.1016/j.ijid.2017.02.016. Epub 2017 Mar 9. Int J Infect Dis. 2017. PMID: 28284914 Free PMC article.
-
Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand.PLoS One. 2017 Jun 29;12(6):e0180560. doi: 10.1371/journal.pone.0180560. eCollection 2017. PLoS One. 2017. PMID: 28662144 Free PMC article.
-
Heterogeneity of dengue transmission in an endemic area of Colombia.PLoS Negl Trop Dis. 2020 Sep 14;14(9):e0008122. doi: 10.1371/journal.pntd.0008122. eCollection 2020 Sep. PLoS Negl Trop Dis. 2020. PMID: 32925978 Free PMC article.
Cited by
-
Dengue pre-vaccination screening test evaluation for the use of dengue vaccine in an endemic area.PLoS One. 2021 Sep 10;16(9):e0257182. doi: 10.1371/journal.pone.0257182. eCollection 2021. PLoS One. 2021. PMID: 34507347 Free PMC article.
-
miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort.Med Microbiol Immunol. 2025 Feb 20;214(1):13. doi: 10.1007/s00430-025-00821-7. Med Microbiol Immunol. 2025. PMID: 39976655 Free PMC article.
-
Understanding the factors contributing to dengue virus and chikungunya virus seropositivity and seroconversion among children in Kenya.PLoS Negl Trop Dis. 2024 Nov 20;18(11):e0012616. doi: 10.1371/journal.pntd.0012616. eCollection 2024 Nov. PLoS Negl Trop Dis. 2024. PMID: 39565798 Free PMC article.
-
Correction: Doum, D., et al. Dengue Seroprevalence and Seroconversion in Urban and Rural Populations in Northeastern Thailand and Southern Laos. Int. J. Environ. Res. Public Health 2020, 17, 9134.Int J Environ Res Public Health. 2021 Feb 4;18(4):1439. doi: 10.3390/ijerph18041439. Int J Environ Res Public Health. 2021. PMID: 33557444 Free PMC article.
-
Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand.PLoS Med. 2025 Jun 17;22(6):e1004631. doi: 10.1371/journal.pmed.1004631. eCollection 2025 Jun. PLoS Med. 2025. PMID: 40526690 Free PMC article.
References
-
- World Health Organization . Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. World Health Organization; Geneva, Switzerland: 2009. - PubMed
-
- Lopez A.D. Global Burden of Disease and Risk Factors. The World Bank; Washington, DC, USA: 2006. - PubMed
-
- World Health Organization . Global Strategy for Dengue Prevention and Control 2012–2020. World Health Organization; Geneva, Switzerland: 2012.
-
- Stanaway J., Shepard D.S., Undurraga E.A., Halasa Y., Yara A., Coffeng L.E., Brady O., Oliver J., Hay S., Simon I., et al. The global burden of dengue: An analysis from the Global Burden of Disease Study 2013. Lancet Infect. Dis. 2016;16:712–723. doi: 10.1016/S1473-3099(16)00026-8. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical